1-4 of 4
María Pozas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Relinf Registry-Based Analysis Shows Overall Survival Improvement with New Therapies for Relapsed or Refractory Large B-Cell Lymphoma: A Study from the Geltamo Group

Mariana Bastos-Oreiro, Pau Abrisqueta Costa, Antonio Gutierrez, Ana Jimenez Ubieto, Maria Pozas, Sonia Gonzalez De Villambrosia, Raul Cordoba, Alberto Lopez Garcia, Elena Perez Ceballos, Belen Navarro, Ana Muntanola, Eva Donato, Eva Diez-baeza, Maria Lourdes Escoda Teigell, Hugo Daniel Luzardo Henriquez, María Peñarrubia-Ponce, Daniel Garcia Belmonte, Emilia Pardal, Claudia Lozada, Armando Lopez-Guillermo, Alejandro Martín García-Sancho
Journal: Blood
Blood (2023) 142 (Supplement 1): 4870.
https://doi.org/10.1182/blood-2023-186594
Published: 2023
Journal Articles

Impact of Prior Bendamustine Exposure on Bispecific Antibody Treatment Outcomes for Patients with B-Cell Lymphoma

Gloria Iacoboni, Angel Serna, Victor Navarro Garces, Ana Jimenez Ubieto, Evelyn Valencia, Alberto Lopez Garcia, Itziar Carro, Sergi Camarillas, Josu Iraola, Lucia Medina, Gala Vega, Maria Pozas, Anna Maria Sureda Balari, Raul Cordoba, Miguel Canales, Francesc Bosch, Pere Barba, Pau Abrisqueta Costa
Journal: Blood
Blood (2023) 142 (Supplement 1): 310.
https://doi.org/10.1182/blood-2023-184883
Published: 2023
Journal Articles

Impact on Survival of the Introduction of New Therapies for Relapsed-Refractory Aggressive B-Cell Lymphoma, Based on the Relinf Registry: A Study By the Spanish Geltamo Group

Mariana Bastos-Oreiro, Ana Jimenez-Ubieto, Sonia González de Villambrosia, Raul Cordoba, Elena Pérez Ceballos, EVA Maria DONATO Martin, Ana Muntañola Prat, Hugo Daniel Luzardo Henriquez, Lourdes Escoda, Maria Jesús Peñarrubia, María Pozas, Alberto Lopez-Garcia, Daniel Garcia, Emilia Pardal, Claudia Salazar Lozada, Alejandro Martín García-Sancho
Journal: Blood
Blood (2022) 140 (Supplement 1): 9501–9503.
https://doi.org/10.1182/blood-2022-166213
Published: 2022
Journal Articles

Validation of the High-Risk Prognostic Score Defined By the Presence of Mutations in NRAS or TP53 in a Cohort of 497 Patients with Acute Myeloid Leukemia

Rosa Ayala, MD PhD, Pau Montesinos, MD PhD, Eva Barragán, PhD, Joaquin Martinez-Lopez, MD, Miguel A. Sanz, Yanira Ruiz-Heredia, Santiago Barrio, Juan Manuel de la Rosa, Inmaculada Rapado, Pilar Martinez, MD, Rafael Colmenares, Maria Pozas, Xabier Gutierrez, María Luz Morales, Noemí Álvarez Sánchez-Redondo
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-137467
Published: 2020